Hyperhomocysteinaemia is an independent risk factor for peripheral arterial disease in a Chinese Han population

In conclusion, HHcy is an independent risk factor for PAD in the Chinese Han population. A prospective and randomized clinical trial of homocysteine lowering therapy in the Chinese population is needed to assess the causal nature of the relationship.